Protective Effect of CXCR4 Antagonist CX807 in a Rat Model of Hemorrhagic Stroke
Open Access
- 25 September 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (19) , 7085
Abstract
Intracerebral hemorrhage (ICH) is a major cause of stroke, with high mortality and morbidity. There is no effective pharmacological therapy for ICH. Previous studies have indicated that CXCR4 antagonists reduced microglia activation, attenuated infiltration of T cells, and improved functional recovery in ischemic stroke animals. The interaction of CXCR4 antagonists and ICH has not been characterized. The purpose of this study is to examine the neuroprotective action of a novel CXCR4 antagonist CX807 against ICH. In primary cortical neuronal and BV2 microglia co-culture, CX807 reduced glutamate-mediated neuronal loss and microglia activation. Adult rats were locally administered with collagenase VII to induce ICH. CX807 was given systemically after the ICH. Early post-treatment with CX807 improved locomotor activity in ICH rats. Brain tissues were collected for qRTPCR and histological staining. ICH upregulated the expression of CXCR4, CD8, TNFα, IL6, and TLR4. The immunoreactivity of IBA1 and CD8, as well as TUNEL labeling, were enhanced in the perilesioned area. CX807 significantly mitigated these responses. In conclusion, our data suggest that CX807 is neuroprotective and anti-inflammatory against ICH. CX807 may have clinical implications for the treatment of hemorrhagic stroke.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (108-2320-B-400-013; 108-2113-M-400-005-MY3)
- National Health Research Institutes, Taiwan (intramural)
This publication has 27 references indexed in Scilit:
- Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke BrainiScience, 2020
- Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic TargetsJournal of Stroke, 2020
- Detection of high serum concentration of CXC chemokine ligand-12 in acute intracerebral hemorrhageClinica Chimica Acta, 2017
- Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental strokeJournal of Neuroinflammation, 2015
- CXCR4 and CXCR7 form a functional receptor unit for SDF‐1/CXCL12 in primary rodent microgliaNeuropathology and Applied Neurobiology, 2013
- Inhibition of CXCL12 Signaling Attenuates the Postischemic Immune Response and Improves Functional Recovery after StrokeJournal of Cerebral Blood Flow & Metabolism, 2013
- CXCR4 Antagonist AMD3100 Protects Blood–Brain Barrier Integrity and Reduces Inflammatory Response After Focal Ischemia in MiceStroke, 2013
- CXCL12-Induced Monocyte-Endothelial Interactions Promote Lymphocyte Transmigration Across an in Vitro Blood-Brain BarrierScience Translational Medicine, 2012
- Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brainJournal of Comparative Neurology, 2006
- Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cellsNeuroscience Letters, 1998